Literature DB >> 1782747

An apolipoprotein CII mutation, CIILys19----Thr' identified in patients with hyperlipidemia.

R A Hegele1, P W Connelly, G F Maguire, M W Huff, L Leiter, B M Wolfe, A J Evans, J A Little.   

Abstract

Five hyperlipidemic patients (one with Type III, three with Type IV, and one with Type V hyperlipoproteinemia) were found on isoelectric focusing to have both the normal isoform of apolipoprotein CII and a second isoform whose isoelectric point was consistent with a single charge change. The structure of the apolipoprotein CII variant was determined to be the same as normal apolipoprotein CII except for replacement of the normal Lys at amino acid residue 19 by Thr (C2K19T). The mutation was absent from 160 apoCII alleles screened from normolipemic subjects. The C2K19T substitution occurs in a domain of apolipoprotein CII postulated to contain a lipid-binding amphipathic alpha-helix. The presence of C2K19T in unrelated hyperlipidemic patients of various racial backgrounds suggests that, in combination with other factors such as mutations in apolipoprotein E, it plays a role in the development of hyperlipoproteinemias.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782747

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  5 in total

1.  Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia.

Authors:  Christopher T Johansen; Jian Wang; Adam D McIntyre; Rebecca A Martins; Matthew R Ban; Matthew B Lanktree; Murray W Huff; Miklós Péterfy; Margarete Mehrabian; Aldons J Lusis; Sekar Kathiresan; Sonia S Anand; Salim Yusuf; Ann-Hwee Lee; Laurie H Glimcher; Henian Cao; Robert A Hegele
Journal:  Circ Cardiovasc Genet       Date:  2011-12-01

2.  Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T).

Authors:  H Wiebusch; J R Nofer; A von Eckardstein; H Funke; U Wahrburg; H Martin; E Köhler; G Assmann
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

Review 3.  Gene-environment interactions in atherosclerosis.

Authors:  R A Hegele
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

4.  Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

Authors:  D S Ng; L A Leiter; C Vezina; P W Connelly; R A Hegele
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

5.  ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1.

Authors:  Inbal Avraham-Davidi; Yona Ely; Van N Pham; Daniel Castranova; Moshe Grunspan; Guy Malkinson; Liron Gibbs-Bar; Oded Mayseless; Gabriella Allmog; Brigid Lo; Carmen M Warren; Tom T Chen; Josette Ungos; Kameha Kidd; Kenna Shaw; Ilana Rogachev; Wuzhou Wan; Philip M Murphy; Steven A Farber; Liran Carmel; Gregory S Shelness; M Luisa Iruela-Arispe; Brant M Weinstein; Karina Yaniv
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.